These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27825121)

  • 1. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.
    Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM
    Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
    Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
    Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
    Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
    Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of long non-coding RNA H19 in various cancers: A meta-analysis based on 15 studies with 1584 patients and the Cancer Genome Atlas data.
    Yu H; Li S; Wu SX; Huang S; Li S; Ye L
    Medicine (Baltimore); 2020 Jan; 99(2):e18533. PubMed ID: 31914026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.
    Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y
    J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non coding RNA XIST as a prognostic cancer marker - A meta-analysis.
    Zhou Q; Hu W; Zhu W; Zhang F; Lin-Lin L; Liu C; Songyang YY; Sun CC; Li D
    Clin Chim Acta; 2018 Jul; 482():1-7. PubMed ID: 29577911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA H19 can predict a poor prognosis and lymph node metastasis: a meta-analysis in human cancer.
    Chen T; Yang P; He ZY
    Minerva Med; 2016 Aug; 107(4):251-8. PubMed ID: 27348443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of lncRNA DANCR expression in human cancers: a systematic review and meta-analysis.
    Liu W; Wang QP; Guo J
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 30910838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
    Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
    Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
    Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
    [No Abstract]   [Full Text] [Related]  

  • 15. Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features.
    Lin Y; Xu L; Wei W; Zhang X; Ying R
    Biomed Res Int; 2016; 2016():4863609. PubMed ID: 27738631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
    Tian S; Liu J; Kong S; Peng L
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-10b expression predicts long-term survival in patients with solid tumor.
    Zhang Y; Wang LJ; Yang HQ; Wang R; Wu HJ
    J Cell Physiol; 2019 Feb; 234(2):1248-1256. PubMed ID: 30191959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PANDAR as a prognostic marker in Chinese cancer.
    Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ
    Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of long noncoding RNA LUCAT1 correlates with a poor clinical outcome in solid tumors: A systematic review and meta-analysis.
    Lv P; Ye T; Yang X; Liu H; Ye Z
    Pathol Res Pract; 2020 Sep; 216(9):153047. PubMed ID: 32825932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.